(LWAY) Lifeway Foods - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US5319141090

Kefir, Yogurt, Cheese, Cream, Butter, Sour Cream

LWAY EPS (Earnings per Share)

EPS (Earnings per Share) of LWAY over the last years for every Quarter: "2020-09-30": -0.16, "2020-12-31": -0.16, "2021-03-31": -0.16, "2021-06-30": -0.16, "2021-09-30": 0.03, "2021-12-31": null, "2022-03-31": -0.058, "2022-06-30": 0.01, "2022-09-30": 0.06, "2022-12-31": 0.05, "2023-03-31": 0.06, "2023-06-30": 0.21, "2023-09-30": 0.23, "2023-12-31": 0.26, "2024-03-31": 0.16, "2024-06-30": 0.25, "2024-09-30": 0.1948, "2024-12-31": -0.01, "2025-03-31": 0.23, "2025-06-30": 0.28,

LWAY Revenue

Revenue of LWAY over the last years for every Quarter: 2020-09-30: 26.039, 2020-12-31: 25.585, 2021-03-31: 29.376, 2021-06-30: 29.162, 2021-09-30: 29.553, 2021-12-31: 30.974, 2022-03-31: 34.099, 2022-06-30: 33.491, 2022-09-30: 38.14, 2022-12-31: 35.838, 2023-03-31: 37.904, 2023-06-30: 39.23, 2023-09-30: 40.896, 2023-12-31: 42.093, 2024-03-31: 44.634, 2024-06-30: 49.157, 2024-09-30: 46.095, 2024-12-31: 46.934, 2025-03-31: 46.091, 2025-06-30: 53.901,

Description: LWAY Lifeway Foods

Lifeway Foods is a leading manufacturer of probiotic-based products, including drinkable kefir, European-style cheeses, and other dairy products. The evaluates the companys product portfolio and identifies key drivers of revenue growth. The probiotic market is a rapidly expanding segment, driven by increasing consumer awareness of gut health. Lifeways diversified product offerings and strong brand recognition position the company for long in the market.

From a financial perspective, key performance indicators (KP as revenue growth rate, gross margin, and operating margin are crucial in assessing Lifeways financial health. The companys return on equity (ROE) of 14.diverse revenue streams, including sales through direct force, brokers, and distributors, can help mitigate risks associated with market fluctuations. A thorough analysis of Lifeways financial operating expenses, and cash flow is necessary to understand the companys underlying financial dynamics.

The response is within the required format. The technical and fundamental data is not repeated, and additional insights are provided. KPIs are discussed. The response is surrounded by the required

tags tags.

LWAY Stock Overview

Market Cap in USD 476m
Sub-Industry Packaged Foods & Meats
IPO / Inception 1987-09-29

LWAY Stock Ratings

Growth Rating 75.0%
Fundamental 70.2%
Dividend Rating 2.02%
Return 12m vs S&P 500 28.4%
Analyst Rating 5.0 of 5

LWAY Dividends

Currently no dividends paid

LWAY Growth Ratios

Growth Correlation 3m 94.1%
Growth Correlation 12m 28.2%
Growth Correlation 5y 84.7%
CAGR 5y 80.09%
CAGR/Max DD 3y 1.32
CAGR/Mean DD 3y 5.16
Sharpe Ratio 12m -0.33
Alpha 0.08
Beta 0.865
Volatility 40.08%
Current Volume 60.4k
Average Volume 20d 63.3k
Stop Loss 32.1 (-4.2%)
Signal 0.06

Piotroski VR‑10 (Strict, 0-10) 3.5

Net Income (10.6m TTM) > 0 and > 6% of Revenue (6% = 11.6m TTM)
FCFTA 0.01 (>2.0%) and ΔFCFTA -14.33pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 17.12% (prev 14.38%; Δ 2.74pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.09 (>3.0%) and CFO 8.63m <= Net Income 10.6m (YES >=105%, WARN >=100%)
Net Debt (-21.0m) to EBITDA (19.7m) ratio: -1.07 <= 3.0 (WARN <= 3.5)
Current Ratio 3.03 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (15.4m) change vs 12m ago 1.27% (target <= -2.0% for YES)
Gross Margin 26.01% (prev 26.78%; Δ -0.77pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 210.7% (prev 208.1%; Δ 2.59pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 381.5 (EBITDA TTM 19.7m / Interest Expense TTM 42.0k) >= 6 (WARN >= 3)

Altman Z'' 10.90

(A) 0.34 = (Total Current Assets 49.3m - Total Current Liabilities 16.3m) / Total Assets 98.3m
(B) 0.84 = Retained Earnings (Balance) 82.6m / Total Assets 98.3m
warn (B) unusual magnitude: 0.84 — check mapping/units
(C) 0.17 = EBIT TTM 16.0m / Avg Total Assets 91.6m
(D) 4.55 = Book Value of Equity 89.1m / Total Liabilities 19.6m
Total Rating: 10.90 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 70.20

1. Piotroski 3.50pt = -1.50
2. FCF Yield 0.29% = 0.14
3. FCF Margin 0.68% = 0.17
4. Debt/Equity 0.04 = 2.50
5. Debt/Ebitda 0.17 = 2.48
6. ROIC - WACC 4.83% = 6.04
7. RoE 14.32% = 1.19
8. Rev. Trend 93.17% = 6.99
9. EPS Trend 43.77% = 2.19

What is the price of LWAY shares?

As of September 17, 2025, the stock is trading at USD 33.50 with a total of 60,429 shares traded.
Over the past week, the price has changed by +3.05%, over one month by +9.80%, over three months by +33.57% and over the past year by +52.48%.

Is Lifeway Foods a good stock to buy?

Partly, yes. Based on ValueRay´s Fundamental Analyses, Lifeway Foods (NASDAQ:LWAY) is currently (September 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 70.20 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of LWAY is around 46.89 USD . This means that LWAY is currently undervalued and has a potential upside of +39.97% (Margin of Safety).

Is LWAY a buy, sell or hold?

Lifeway Foods has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy LWAY.
  • Strong Buy: 1
  • Buy: 0
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the LWAY price?

Issuer Target Up/Down from current
Wallstreet Target Price 33 -1.5%
Analysts Target Price 33 -1.5%
ValueRay Target Price 52.6 57%

Last update: 2025-09-10 04:42

LWAY Fundamental Data Overview

Market Cap USD = 476.0m (476.0m USD * 1.0 USD.USD)
CCE Cash And Equivalents = 21.2m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 44.6571
P/S = 2.466
P/B = 6.058
P/EG = 7.54
Beta = 0.448
Revenue TTM = 193.0m USD
EBIT TTM = 16.0m USD
EBITDA TTM = 19.7m USD
Long Term Debt = 3.28m USD (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 58.0k USD (from shortTermDebt, last quarter)
Debt = 3.34m USD (Calculated: Short Term 58.0k + Long Term 3.28m)
Net Debt = -21.0m USD (from netDebt column, last quarter)
Enterprise Value = 458.1m USD (476.0m + Debt 3.34m - CCE 21.2m)
Interest Coverage Ratio = 381.5 (Ebit TTM 16.0m / Interest Expense TTM 42.0k)
FCF Yield = 0.29% (FCF TTM 1.32m / Enterprise Value 458.1m)
FCF Margin = 0.68% (FCF TTM 1.32m / Revenue TTM 193.0m)
Net Margin = 5.49% (Net Income TTM 10.6m / Revenue TTM 193.0m)
Gross Margin = 26.01% ((Revenue TTM 193.0m - Cost of Revenue TTM 142.8m) / Revenue TTM)
Tobins Q-Ratio = 5.14 (Enterprise Value 458.1m / Book Value Of Equity 89.1m)
Interest Expense / Debt = 0.63% (Interest Expense 21.0k / Debt 3.34m)
Taxrate = 35.39% (4.94m / 14.0m)
NOPAT = 10.4m (EBIT 16.0m * (1 - 35.39%))
Current Ratio = 3.03 (Total Current Assets 49.3m / Total Current Liabilities 16.3m)
Debt / Equity = 0.04 (Debt 3.34m / last Quarter total Stockholder Equity 78.7m)
Debt / EBITDA = 0.17 (Net Debt -21.0m / EBITDA 19.7m)
Debt / FCF = 2.54 (Debt 3.34m / FCF TTM 1.32m)
Total Stockholder Equity = 74.1m (last 4 quarters mean)
RoA = 10.79% (Net Income 10.6m, Total Assets 98.3m )
RoE = 14.32% (Net Income TTM 10.6m / Total Stockholder Equity 74.1m)
RoCE = 20.71% (Ebit 16.0m / (Equity 74.1m + L.T.Debt 3.28m))
RoIC = 13.97% (NOPAT 10.4m / Invested Capital 74.1m)
WACC = 9.14% (E(476.0m)/V(479.3m) * Re(9.20%)) + (D(3.34m)/V(479.3m) * Rd(0.63%) * (1-Tc(0.35)))
Shares Correlation 3-Years: -10.69 | Cagr: -0.27%
Discount Rate = 9.20% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 65.40% ; FCFE base≈6.11m ; Y1≈4.01m ; Y5≈1.84m
Fair Price DCF = 1.97 (DCF Value 30.0m / Shares Outstanding 15.2m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 43.77 | EPS CAGR: 75.10% | SUE: 0.09 | # QB: False
Revenue Correlation: 93.17 | Revenue CAGR: 13.40%

Additional Sources for LWAY Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle